Genelux (GNLX) Operating Leases (2022 - 2026)
Genelux (GNLX) recorded quarterly Operating Leases of $2.5 million in Q1 2026, up 98.33% quarter-over-quarter from $1.3 million in Q4 2025, and up 39.62% on a YoY basis from $1.8 million in Q1 2025.
Genelux (GNLX) Operating Leases (2022 - 2026) Analysis & Trends
Genelux's Operating Leases history runs 5 years deep, the most recent figure standing at $2.5 million for Q1 2026.
- In Q1 2026, Operating Leases rose 39.62% year-over-year to $2.5 million; the TTM figure through Mar 2026 stood at $2.5 million (up 39.62% YoY), while the FY2025 annual figure was $1.3 million, down 18.26% from the prior year.
- Operating Leases was $2.5 million for Q1 2026 at Genelux, up from $1.3 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $2.5 million in Q1 2026 to a low of $1.2 million in Q4 2022.
- Historically, Operating Leases has averaged $1.7 million across 5 years, with a median of $1.8 million in 2023.
- The sharpest annual moves came in 2023 and 2025: Operating Leases jumped 60.31% in 2023, then sank 38.33% in 2025.
- A 5-year view of Operating Leases shows it stood at $1.2 million in 2022, then jumped by 60.31% to $1.9 million in 2023, then fell by 17.52% to $1.5 million in 2024, then decreased by 18.26% to $1.3 million in 2025, then soared by 98.33% to $2.5 million in 2026.
- The last three Operating Leases figures came in at $2.5 million (Q1 2026), $1.3 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.50 Mn |
| Dec 31, 2025 | 1.26 Mn |
| Sep 30, 2025 | 1.27 Mn |
| Jun 30, 2025 | 1.36 Mn |
| Mar 31, 2025 | 1.79 Mn |
| Dec 31, 2024 | 1.54 Mn |
| Sep 30, 2024 | 2.04 Mn |
| Jun 30, 2024 | 2.21 Mn |
| Mar 31, 2024 | 2.37 Mn |
| Dec 31, 2023 | 1.87 Mn |
| Sep 30, 2023 | 1.29 Mn |
| Jun 30, 2023 | 1.81 Mn |
| Mar 31, 2023 | 1.95 Mn |
| Dec 31, 2022 | 1.16 Mn |